The Fédération Équestre Internationale (FEI) has added Metacam for Horses to its 'list of detection times'.

According to the manufacturer, Boehringher Ingelheim Vetmedica, Metacam (meloxicam) is the first preferential COX-2 inhibitor to be added to this list, and has stated plasma and urine detection times of 72 hours administered intravenously or orally¹. This is the shortest urine detection time of the NSAIDs available for use in horses, and compares to the 168-hour (7 days) detection time for phenylbutazone stated by the FEI.

Craig Beck, equine sales and marketing manager for Boehringer Ingelheim in the UK and Ireland said: "We have been very happy to work in partnership with the FEI to provide the robust data that has supported the FEI in their analysis of Metacam. Metacam is an important addition to the FEI list, that will help vets treating competition horses. There is now a modern and proven NSAID which extends the therapeutic options available to vets."

Metacam is licensed in horses for the alleviation of inflammation and relief of pain associated with musculo-skeletal disorders or colic.

For further information, please contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.

1 Detection Time agreed with the European Horse Racing Scientific Liaison Committee (EHSLC)

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.